Cargando…
A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the pre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560646/ https://www.ncbi.nlm.nih.gov/pubmed/22936198 http://dx.doi.org/10.12659/MSM.883339 |
_version_ | 1782257825784791040 |
---|---|
author | Schaumann, Reiner Knoop, Nicolas Genzel, Gelimer H. Losensky, Kevin Rosenkranz, Christiane Stîngu, Catalina S. Schellenberger, Wolfgang Rodloff, Arne C. Eschrich, Klaus |
author_facet | Schaumann, Reiner Knoop, Nicolas Genzel, Gelimer H. Losensky, Kevin Rosenkranz, Christiane Stîngu, Catalina S. Schellenberger, Wolfgang Rodloff, Arne C. Eschrich, Klaus |
author_sort | Schaumann, Reiner |
collection | PubMed |
description | BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the present study investigated the discrimination potential of MALDI-TOF MS among extended-spectrum-beta-lactamase (ESBL) or metallo-beta-lactamases- (MBL) producing and the nonproducing strains of Escherichia coli (n=19), Klebsiella pneumoniae (n=19), and Pseudomonas aeruginosa (n=38), respectively. MATERIAL/METHODS: We used a MALDI-TOF MS protocol, usually applied for species identification, in order to integrate a screening method for beta-lactamases into the routine species identification workflow. The acquired spectra were analyzed by visual inspection, statistical similarity analysis and support vector machine (SVM) classification algorithms. RESULTS: Neither visual inspection nor mathematical similarity analysis allowed discrimination between spectra of beta-lactamase-producing and the nonproducing strains, but classification within a species by SVM-based algorithms could achieve a correct classification rate of up to 70%. CONCLUSIONS: This shows that MALDI-TOF MS has definite potential to discriminate antibiotic-resistant strains due to ESBL and MBL production from nonproducing strains, but this performance is not yet sufficiently reliable for routine microbiological diagnostics. |
format | Online Article Text |
id | pubmed-3560646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-35606462013-04-24 A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry Schaumann, Reiner Knoop, Nicolas Genzel, Gelimer H. Losensky, Kevin Rosenkranz, Christiane Stîngu, Catalina S. Schellenberger, Wolfgang Rodloff, Arne C. Eschrich, Klaus Med Sci Monit Diagnostics and Medical Technology BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the present study investigated the discrimination potential of MALDI-TOF MS among extended-spectrum-beta-lactamase (ESBL) or metallo-beta-lactamases- (MBL) producing and the nonproducing strains of Escherichia coli (n=19), Klebsiella pneumoniae (n=19), and Pseudomonas aeruginosa (n=38), respectively. MATERIAL/METHODS: We used a MALDI-TOF MS protocol, usually applied for species identification, in order to integrate a screening method for beta-lactamases into the routine species identification workflow. The acquired spectra were analyzed by visual inspection, statistical similarity analysis and support vector machine (SVM) classification algorithms. RESULTS: Neither visual inspection nor mathematical similarity analysis allowed discrimination between spectra of beta-lactamase-producing and the nonproducing strains, but classification within a species by SVM-based algorithms could achieve a correct classification rate of up to 70%. CONCLUSIONS: This shows that MALDI-TOF MS has definite potential to discriminate antibiotic-resistant strains due to ESBL and MBL production from nonproducing strains, but this performance is not yet sufficiently reliable for routine microbiological diagnostics. International Scientific Literature, Inc. 2012-09-01 /pmc/articles/PMC3560646/ /pubmed/22936198 http://dx.doi.org/10.12659/MSM.883339 Text en © Med Sci Monit, 2012 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. |
spellingShingle | Diagnostics and Medical Technology Schaumann, Reiner Knoop, Nicolas Genzel, Gelimer H. Losensky, Kevin Rosenkranz, Christiane Stîngu, Catalina S. Schellenberger, Wolfgang Rodloff, Arne C. Eschrich, Klaus A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title_full | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title_fullStr | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title_full_unstemmed | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title_short | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry |
title_sort | step towards the discrimination of beta-lactamase-producing clinical isolates of enterobacteriaceae and pseudomonas aeruginosa by maldi-tof mass spectrometry |
topic | Diagnostics and Medical Technology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560646/ https://www.ncbi.nlm.nih.gov/pubmed/22936198 http://dx.doi.org/10.12659/MSM.883339 |
work_keys_str_mv | AT schaumannreiner asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT knoopnicolas asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT genzelgelimerh asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT losenskykevin asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT rosenkranzchristiane asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT stingucatalinas asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT schellenbergerwolfgang asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT rodloffarnec asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT eschrichklaus asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT schaumannreiner steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT knoopnicolas steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT genzelgelimerh steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT losenskykevin steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT rosenkranzchristiane steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT stingucatalinas steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT schellenbergerwolfgang steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT rodloffarnec steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry AT eschrichklaus steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry |